# A dipeptidyl peptidase-4 inhibitor, sitagliptin, exerts anti-inflammatory effects in type 2 diabetic patients

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/a-dipeptidyl-peptidase-4-inhibitor-sitagliptin-exerts-anti-inflammatory-effects/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Noriko Satoh‐Asahara,Y. Sasaki,Hiromichi Wada,Mayu Tochiya,Azusa Iguchi,Reiko Nakagawachi,Shinji Odori,Shigeo Kono,Koji Hasegawa,Akira Shimatsu |
| Citations | 199 |
| DOI | 10.1016/j.metabol.2012.09.004 |
| Fields | Medicine,Neuroscience |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2042503458 |
| PMID | 23062489 |
| Type | article |
| Year | 2012 |

## Paper authors

- [Mayu Tochiya](https://scholariq.org/researchers/mayu-tochiya/)

## Paper journal

- [Metabolism](https://scholariq.org/journals/metabolism/)

## Paper primary topic

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)

## Paper topics

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)
- [Peptidase Inhibition and Analysis](https://scholariq.org/topics/peptidase-inhibition-and-analysis/)
- [Neuropeptides and Animal Physiology](https://scholariq.org/topics/neuropeptides-and-animal-physiology/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.